These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8084118)

  • 21. Effect of elevated plasma-free fatty acids on thromboxane release in patients with coronary artery disease.
    Lewy RI
    Haemostasis; 1980; 9(3):134-40. PubMed ID: 7372200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombocyte function and the prostacyclin-thromboxane system in patients with acute myocardial infarct].
    Aliavi AL
    Vrach Delo; 1988 Mar; (3):42-4. PubMed ID: 3293319
    [No Abstract]   [Full Text] [Related]  

  • 23. Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms.
    Willerson JT; Campbell WB; Winniford MD; Schmitz J; Apprill P; Firth BG; Ashton J; Smitherman T; Bush L; Buja LM
    Am J Cardiol; 1984 Dec; 54(10):1349-54. PubMed ID: 6391133
    [No Abstract]   [Full Text] [Related]  

  • 24. Significance of thromboxane A2 in myocardial ischemia in patients with coronary artery disease.
    Tada M; Kuzuya T; Inoue M; Kodama K; Fukushima M; Abe H
    Adv Myocardiol; 1980; 2():397-405. PubMed ID: 7423053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostacyclin and thromboxane metabolites in diabetes.
    Davis TM; Mitchell MD; Turner RC
    Lancet; 1979 Oct; 2(8146):789-90. PubMed ID: 90875
    [No Abstract]   [Full Text] [Related]  

  • 26. Prostacyclin and thromboxane levels during cardiac ischemia in dogs.
    Prosdocimi M; Tessari F; Finesso M; Gorio A; Dejana E; Languino LR; Del Maschio A; de Gaetano G
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():93-6. PubMed ID: 3159235
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunoreactive prostacyclin and thromboxane metabolites in normal pregnancy and the puerperium.
    Greer IA; Walker JJ; McLaren M; Bonduelle M; Cameron AD; Calder AA; Forbes CD
    Br J Obstet Gynaecol; 1985 Jun; 92(6):581-5. PubMed ID: 3890936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature.
    Lewy RI; Wiener L; Walinsky P; Lefer AM; Silver MJ; Smith JB
    Circulation; 1980 Jun; 61(6):1165-71. PubMed ID: 7371128
    [No Abstract]   [Full Text] [Related]  

  • 29. Drugs that modulate prostaglandins, prostacyclin, and thromboxane A2.
    Moncada S; Vane JR
    Drug Ther; 1982; ():37-65. PubMed ID: 7049651
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prostacyclin and thromboxane in thrombosing atherosclerotic diseases].
    Viinikka L
    Duodecim; 1981; 97(13):925-7. PubMed ID: 7032876
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes of platelet aggregation, serum thromboxane and prostacyclin in lung cancer and pulmonary metastatic patients following operation].
    Takeda H; Kashimura Y; Takeoka T; Hashimoto M; Tanabe T
    Kyobu Geka; 1984 Sep; 37(10):773-7. PubMed ID: 6389949
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of orally administered atenolol on the coronary hemodynamics and prostaglandin metabolism in angina pectoris patients.
    Kurita A; Takase B; Uehata A; Nishioka T; Satomura K; Nagayoshi H; Mizuno K
    Angiology; 1994 Mar; 45(3):219-24. PubMed ID: 8129203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thromboxane, prostaglandin I2 (epoprostenol), and the hemodynamic changes in equine endotoxin shock.
    Bottoms GD; Templeton CB; Fessler JF; Johnson MA; Roesel OF; Ewert KM; Adams SB
    Am J Vet Res; 1982 Jun; 43(6):999-1002. PubMed ID: 7049018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Levels of neuropeptide Y and thromboxane B2 in patients with variant angina].
    Salomon P; Halawa B
    Pol Arch Med Wewn; 1998 Oct; 100(4):313-20. PubMed ID: 10335040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Helium-neon laser therapy in the combined treatment of unstable stenocardia].
    Korochkin IM; Kapustina GM; Babenko EV; Zhuravleva NIu
    Sov Med; 1990; (3):12-5. PubMed ID: 1973307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thromboxane, prostacyclin, and hemodynamic events in primate endotoxin shock.
    Fletcher JR; Ramwell PW; Harris RH
    Adv Shock Res; 1981; 5():143-8. PubMed ID: 7030016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lectin-induced chemiluminescence of peripheral blood neutrophils in patients with ischemic heart disease before and after blood irradiation with helium-neon laser].
    Kipshidze NN; Khomeriki SG; Kubatiev AA; Korochkin IM; Denisov SM; Shliapnikov VN
    Kardiologiia; 1992 Jan; 32(1):53-6. PubMed ID: 1319516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of the "secondary exacerbation" phenomenon in patients with stenocardia treated with helium-neon laser therapy].
    Korochkin IM; Kartelishev AV; Babushkina GV; Kapustina GM
    Sov Med; 1989; (8):14-6. PubMed ID: 2814659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasma thromboxane B2 and capacity of the aorta to produce prostacyclin in arteriopathies of the lower extremities].
    Jouve R; Rolland PH; Pellegrin E; Mercier C; Delboy C; Serradimigni A
    J Mal Vasc; 1983; 8(3):221-5. PubMed ID: 6355348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A comparative analysis of the results of using different methods of helium-neon laser therapy in patients with stable stenocardia].
    Iurlov VM; Kul'baba IH
    Lik Sprava; 1996; (1-2):73-6. PubMed ID: 9005112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.